Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Washington Court Hotel

25 sep 2013 8:00 a.m. - 27 sep 2013 5:00 p.m.

525 New Jersey Avenue NW, Washington, DC 20001

DIA/FDA Oligonucleotide-based Therapeutics Conference

Session Chair(s)

Session  Chair Invited

Session Chair Invited

United States

Speaker(s)

Scott  Henry, PHD

Discussant and Panelist: Nonclinical Track

Scott Henry, PHD

Ionis Pharmaceuticals, Inc., United States

Senior Vice President, Nonclinical Development

Arthur A. Levin, PHD

Discussant and Panelist: Nonclinical Track

Arthur A. Levin, PHD

Avidity Biosciences, United States

Distinguished Scientist

Daniel  Capaldi, PHD

Discussant and Panelist: CMC Track

Daniel Capaldi, PHD

Ionis Pharmaceuticals, Inc, United States

Vice President, Analytical and Process Development

René  Thürmer, PHD

Discussant and Panelist: CMC Track

René Thürmer, PHD

Federal Institute for Drugs and Medical Devices, Germany

Quality Assessor

James D. Thompson, PHD

Discussant and Panelist: Clinical Track

James D. Thompson, PHD

Quark Pharmaceuticals Inc., United States

Vice President, Pharmaceutical Development

Saraswathy V. Nochur, PHD, MSC

Discussant and Panelist: Clinical Track

Saraswathy V. Nochur, PHD, MSC

Alnylam Pharmaceuticals, United States

Chief Regulatory Officer

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.